-
May 09, 2013
Teva's partnership with Alexza looks like an expensive gamble.
-
May 07, 2013
Mobile Mini reported first quarter earnings May 6 that were impressive to say the least. With its stock sitting near ...
-
April 26, 2013
Flooring retailer Lumber Liquidators (NYSE:LL) reported strong earnings April 24. By every financial metric it was a ...
-
April 23, 2013
TI's outlook is improving, but core market growth is still lagging.
-
April 18, 2013
Investor enthusiasm for gold has been falling by the wayside. For portfolios, that could mean it's time to short the ...
-
April 11, 2013
Progressive is still a fine insurance company, but the growth premium seems overdone today.
-
March 21, 2013
Oracle's surprisingly weak fiscal third quarter increases the near-term risks, but also creates a long-term ...
-
February 15, 2013
We maintain a Neutral recommendation on L-3 Communications Holdings Inc. (LLL) reflecting our concerns regarding the ...
-
February 15, 2013
Navigators Group Inc.'s (NAVG) fourth-quarter adjusted earnings of 59 cents breezed past the Zacks Consensus ...
-
February 14, 2013
Mylan (MYL) extended its three-year old partnership with India-based Biocon Limited. The companies recently signed a ...
-
February 14, 2013
Peregrine Pharmaceuticals (PPHM) recently announced phase II data on its oncology candidate, bavituximab. The ...
-
February 13, 2013
Roche (RHHBY) recently entered into a drug discovery collaboration with privately-held RQx Pharmaceuticals, Inc. ...
-
February 13, 2013
While earnings for last week remained mixed, those firms not tied too heavily to personal computer sales continue to ...
-
February 13, 2013
Shire plc (SHPG) recently settled its pending litigation with Impax Laboratories, Inc. (IPXL). The litigation is ...
-
February 13, 2013
In coming months, moviegoers will be treated to a pair of hagiographic films about Steve Jobs. In early April, we'll ...
-
February 12, 2013
Cardiome Pharma Corp. (CRME) recently selected privately-held Quintiles for providing lifecycle safety and global ...
-
February 12, 2013
Shire plc (SHPG) recently announced that the company has initiated a phase III study to evaluate the efficacy and ...
-
February 11, 2013
Acorda Therapeutics, Inc. (ACOR) recently announced that data from preclinical studies evaluating glial growth ...
-
February 11, 2013
Novo Nordisk (NVO) recently faced a setback when the US Food and Drug Administration (FDA) declined to approve its ...
-
February 11, 2013
Eli Lilly and Company (LLY) recently provided an update on its rheumatoid arthritis candidate, tabalumab. The ...
